Pharma Explained
Features
Kotter International
Meaningful Integration: Building culture and success in pharma M&A
After the pharmaceutical industry’s muted mergers and acquisitions (M&A) landscape in 2024, Nick Petschek, EMEA MD at Kotter International suggests many expect M&A to pick back up in 2025. Read more
LeoWolfert Shutterstock
Optimised R&D processes are paramount to keep pace with the market
Without aligned process improvements across Regulatory Affairs, Quality and Pharmacovigilance/Drug Safety, pharma companies risk limiting their overall market performance, says MAIN5’s Tobias Hitziger. Read more
Thermo Fisher
Leaders in Pharma: Thermo Fisher Scientific
In the latest episode of MedTalk, we delve into the journey of leadership in the pharmaceutical industry with Urmi Prasad Richardson, President of EMEA at Thermo Fisher Scientific. Read more
Tower Cold Chain
Sustainability that counts: The future of temperature-controlled logistics
Niall Balfour, chief executive officer, Tower Cold Chain examines the growing importance of measurable sustainability in temperature-controlled logistics. Read more
DeSci Labs
Q&A: How novelty scores can affect pharma
Philipp Koellinger, co-founder and CEO DeSci Labs, explains what novelty scores are, and the effect they can have on the pharmaceutical sector. Read more